Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

An Observational Study of the Medical-Grade Wireless Wearable Data for Predicting Hypoxemia Risk and Evaluating Workflow Efficiency in Patients Undergoing Sedated Gastrointestinal Endoscopy

15. november 2026 opdateret af: Min Su

This prospective observational study aims to develop and evaluate prediction models for low blood oxygen levels (hypoxemia) in adult patients undergoing gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia. The study will also assess patient flow and waiting times during different stages of endoscopy care.

Low blood oxygen levels may occur during anesthesia and recovery from endoscopy. Medical-grade wireless wearable monitoring devices can continuously record vital signs as patients move through preparation, examination, transfer, and recovery areas. The investigators will analyze monitoring data, routine clinical information, and the time spent at different stages of care to identify factors associated with hypoxemia and potentially avoidable nonmedical waiting time.

This study will be conducted at the First Affiliated Hospital of Chongqing Medical University. Approximately 772 adult participants are planned for enrollment in the current study phase. All participants will receive routine anesthesia, endoscopy, monitoring, and recovery care. The study will not change clinical treatment decisions, and prediction model results will not be used to guide patient care.

The findings may support future improvements in patient safety monitoring, hypoxemia risk assessment, and endoscopy workflow efficiency. Participants may not receive any direct medical benefit from taking part in this study.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Detaljeret beskrivelse

Background and Rationale Hypoxemia is an important safety concern during gastrointestinal endoscopy under anesthesia. Changes in oxygen saturation may occur during both the procedure and the recovery period. Continuous monitoring using medical-grade wireless wearable devices may provide useful physiological data for predicting hypoxemia. In addition, the time required for different stages of endoscopy care may be influenced by patient characteristics, clinical needs, and operational factors. Distinguishing medically necessary care from avoidable nonmedical waiting may help improve workflow efficiency without compromising patient safety.

Study Design and Data Collection This investigator-initiated, prospective observational cohort study will be conducted at the First Affiliated Hospital of Chongqing Medical University. The current phase involves single-center model development and internal validation.

Adult patients scheduled for gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia will be assessed for eligibility and enrolled after written informed consent.

Medical-grade wireless wearable monitoring devices already used in routine clinical care will provide continuous physiological data, including peripheral oxygen saturation (SpO2), heart rate, and signal quality information. Additional study data will include routine pre-anesthesia assessments, patient characteristics, anesthesia and endoscopy records, airway management, recovery information, and workflow timestamps. Simple noninvasive measurements, including neck circumference and thyromental distance, will also be collected.

Hypoxemia Prediction Two prediction objectives will be evaluated. Model A will use information available before the first administration of anesthetic medication to predict hypoxemia occurring between the first anesthetic dose and endoscope removal.

Model B will evaluate the risk of hypoxemia during recovery, from completion of handover to the recovery area until the patient first meets discharge criteria. Development of Model B will depend on the availability of sufficient outcome events and data.

Hypoxemia will be defined as an SpO2 below 90%, after excluding measurement artifacts. Prediction models will be developed and internally validated using prespecified statistical and machine-learning methods. Additional temporal and external validation may be conducted in subsequent study phases after the required approvals.

Workflow Efficiency Assessment Standardized timestamps will be collected across patient check-in, preparation, monitoring, examination, transfer, recovery, discharge, and room turnover. Risk-adjusted analyses will assess variations in the duration of different workflow stages.

The main workflow efficiency outcome will be the cumulative duration of system-attributable nonmedical waiting time, confirmed by structured documentation of operational causes. Time required for necessary medical treatment, monitoring, and recovery will not be classified as avoidable waiting.

Patient Safety and Study Procedures This study is observational and will not alter routine anesthesia, endoscopy, monitoring, treatment, recovery, or discharge decisions. Prediction model results will not be disclosed to the clinical team for decision-making during the current study phase.

Research data will be de-identified and handled using appropriate data protection procedures. Available hospital records may be reviewed within 24 hours after discharge from the endoscopy center to identify relevant safety events. No additional invasive procedures or study-directed treatments will be performed.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

772

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Kina, 400016
        • The First Affiliated Hospital of Chongqing Medical University
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

The study population will consist of adult patients aged 18 years or older who are scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia at the First Affiliated Hospital of Chongqing Medical University, China. Potential participants will be identified through routine pre-anesthesia assessment and outpatient clinical services. Eligible patients with an ASA-PS classification of I-III who receive routine medical-grade wireless wearable monitoring will be invited to participate after screening. Written informed consent will be obtained before enrollment. Approximately 772 participants are planned for the current single-center observational study.

Beskrivelse

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia, with routine medical-grade wireless wearable monitoring.
  • American Society of Anesthesiologists Physical Status (ASA-PS) classification I-III before anesthesia.
  • Able to understand the study information, voluntarily agree to participate, and provide written informed consent.

Exclusion Criteria:

  • Refusal to participate in the study.
  • Emergency endoscopy.
  • Preprocedural hypoxemia requiring advanced respiratory support.
  • Uncontrolled severe cardiopulmonary disease before the procedure.
  • Requirement for general anesthesia with endotracheal intubation, intensive care unit (ICU)-level support, or planned transfer to the ICU after the procedure.
  • Active major bleeding, a clearly full stomach, an anticipated difficult airway requiring a special anesthetic strategy, or other extremely high-risk conditions unsuitable for routine anesthesia management in an endoscopy center.
  • Missing critical outcome information that prevents determination of the primary safety outcome.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Patients Undergoing Gastrointestinal Endoscopy Under Anesthesia

This cohort consists of adult patients aged 18 years or older who are scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia at the First Affiliated Hospital of Chongqing Medical University. Eligible patients have an American Society of Anesthesiologists Physical Status (ASA-PS) classification of I-III and provide written informed consent. All participants receive routine anesthesia, endoscopic examination, and medical-grade wireless wearable monitoring according to standard clinical practice. Physiological monitoring data, clinical information, and workflow timestamps will be collected prospectively for hypoxemia prediction model development and workflow efficiency assessment. No additional study-directed clinical intervention will be performed.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Incidence of Hypoxemia During Gastrointestinal Endoscopy
Tidsramme: From the first administration of anesthetic medication until endoscope removal, during the endoscopy procedure.

The proportion of participants experiencing at least one episode of hypoxemia between the first administration of anesthetic medication (T6) and endoscope removal (T8). Hypoxemia is defined as peripheral oxygen saturation (SpO2) below 90% at any time, after exclusion of measurement artifacts caused by movement, poor perfusion, or sensor displacement. Events will be adjudicated using monitoring data and clinical records.

From the first administration of anesthetic medication until endoscope removal, during the endoscopy procedure.
Cumulative System-Attributable Nonmedical Waiting Time
Tidsramme: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

The cumulative duration, in minutes, of system-attributable nonmedical waiting time per participant. Waiting episodes must have a documented operational cause, traceable start and end times, and no ongoing medical need for treatment, observation, or technical management. Operational causes include delays related to equipment, procedure rooms, staffing, recovery beds, transportation, handover, documentation, patient education, accompanying persons, cleaning, or supply preparation. Medically necessary care and recovery time will be excluded.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Incidence of Hypoxemia During Postanesthesia Recovery
Tidsramme: From completion of handover to the postanesthesia recovery area until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of eligible participants experiencing hypoxemia (SpO2 below 90%, after artifact exclusion) after completion of handover to the recovery area (T10) and before first meeting discharge criteria (T12). The analysis will include participants without the recovery-period target event at T10 who have the required landmark variables. Formal model development is conditional on sufficient outcome events.

From completion of handover to the postanesthesia recovery area until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Severe Hypoxemia
Tidsramme: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants experiencing severe hypoxemia, defined as SpO2 below 75%, or SpO2 between 75% and 90% lasting at least 60 seconds, according to the study protocol.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Ratio of Hypoxemia Area Under the Curve to Duration
Tidsramme: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The area under the SpO2 curve for measurements below 90% divided by the cumulative duration of SpO2 below 90%, according to the prespecified analysis methodology.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Clinically Recognized Respiratory Events
Tidsramme: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The number and proportion of participants with clinically recognized apnea, airway obstruction, laryngospasm, bronchospasm, regurgitation, or aspiration. Event types will be reported separately.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Airway Interventions
Tidsramme: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The number and proportion of participants requiring positional adjustment, jaw thrust, increased oxygen flow, oropharyngeal or nasopharyngeal airway placement, positive-pressure mask ventilation, or unplanned tracheal intubation. Intervention types will be reported separately.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Hypotension
Tidsramme: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants with systolic blood pressure below 90 mmHg or a decrease greater than 30% from baseline. Treatment for hypotension will also be documented.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Bradycardia
Tidsramme: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants with heart rate below 50 beats per minute. Treatment for bradycardia will also be documented.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Occurrence of Major Clinical Complications
Tidsramme: From check-in at the endoscopy center through 24 hours after actual departure from the endoscopy center.

The number and type of major clinical complications, including severe gastrointestinal bleeding, gastrointestinal perforation, unplanned emergency department transfer, intensive care unit admission or hospitalization, cardiac arrest, and death. Individual event categories will be reported separately.

From check-in at the endoscopy center through 24 hours after actual departure from the endoscopy center.
Total Endoscopy Center Length of Stay
Tidsramme: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

Total time in minutes from endoscopy center check-in (T1) to actual departure from the endoscopy center (T13).

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.
Duration of Individual Endoscopy Workflow Stages
Tidsramme: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each consecutive workflow stage will be assessed separately.

Duration in minutes of each adjacent workflow stage from T1 through T13, including preparation, examination, transfer, recovery, and discharge-related stages. Stage-specific values will be reported.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each consecutive workflow stage will be assessed separately.
Procedure Room Turnover Time
Tidsramme: From departure of the participant from the procedure area until the next patient enters the same procedure room, on the day of the endoscopy procedure.

Time in minutes from a participant leaving the procedure area (T9) until the next patient enters the same procedure room (T14). Prespecified exceptions will be excluded or reported separately.

From departure of the participant from the procedure area until the next patient enters the same procedure room, on the day of the endoscopy procedure.
Risk-Adjusted Excess Workflow Duration
Tidsramme: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each workflow stage will be evaluated separately.

The difference between observed and expected workflow duration estimated using prespecified risk-adjusted stage-specific time models. Results will be evaluated by workflow stage.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each workflow stage will be evaluated separately.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Su Min, First Affiliated Hospital of Chongqing Medical University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. december 2026

Primær færdiggørelse (Anslået)

30. april 2028

Studieafslutning (Anslået)

30. april 2028

Datoer for studieregistrering

Først indsendt

7. november 2026

Først indsendt, der opfyldte QC-kriterier

15. november 2026

Først opslået (Faktiske)

18. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

15. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • ZZ2026-0829-01

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

De-identified individual participant data (IPD) may be made available upon reasonable request to the corresponding author following publication of the primary study findings. Data sharing will be subject to approval by the relevant institutional ethics committee and execution of a data use agreement.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .